All Kidney Tests

All Kidney Tests brings together blood and urine labs that show how well your kidneys filter, balance fluids and minerals, and protect long-term health. Kidney problems often start silently, especially with diabeteshigh blood pressure, heart disease, or a family history of kidney failure.

A proactive approach pairs creatinine with estimated GFR (eGFR) and, when helpful, cystatin?C for filtration; urine albumin-to-creatinine ratio (ACR) and urinalysis to detect kidney damage; and electrolytes/CO2 to assess acid–base and safety. Add targeted testing for UTIsstonesprotein in urine, or hematuria based on symptoms. These labs support screeningdiagnosisstaging, and monitoring, but they do not replace a clinician’s evaluation, imaging, or urgent care when needed.

Signs, Symptoms & Related Situations

  • Often no symptoms early: abnormal labs on a routine check

  • Urinary clues: foamy urine (protein), blood in urine, frequent nighttime urination, burning/urgency (UTI signs), kidney-stone colic

  • Whole-body: ankle/leg swelling, fatigue, poor appetite, nausea, itchy skin, high blood pressure

  • Risk contexts: diabetes, hypertension, cardiovascular disease, obesity, recurrent UTIs/stones, autoimmune disease, long-term NSAID use, family history of kidney failure

  • Seek urgent care now: chest pain, severe shortness of breath, confusion, very low urine output, severe flank pain, high fever, or rapidly worsening swelling

All symptoms and risks should be reviewed by a qualified clinician.

Why These Tests Matter

What testing can do

  • Detect kidney disease early and stage risk using eGFR and albuminuria (ACR)

  • Differentiate causes (e.g., dehydration/AKI vs. chronic kidney disease; infection vs. stones vs. glomerular disease) with urinalysis and targeted add-ons

  • Monitor complications—electrolytes, bicarbonate (CO2), mineral-bone markers, and anemia/iron indices

What testing cannot do

  • Identify the exact cause in every case—some situations require imaging, serologies, or biopsy

  • Replace blood-pressure/diabetes management or medication review

  • Provide treatment or dosing advice—use results to plan with your clinician

What These Tests Measure (at a glance)

  • Creatinine & eGFR: core measure of filtration; eGFR <60 for ≥3 months suggests CKD. Trends matter more than one value.

  • Cystatin?C (± eGFRcys): refines/confirm eGFR when creatinine is borderline or muscle mass is unusual.

  • Urine Albumin-to-Creatinine Ratio (ACR): estimates albumin loss—A1 <30A2 30–299A3 ≥300?mg/g. Repeat to confirm persistence.

  • Urinalysis with Microscopy: protein, blood, glucose; casts (RBC casts suggest glomerular disease); crystals (stone risk); nitrite/leukocyte esterase (infection).

  • Electrolytes & Acid–Base: Na?/K?/Cl? and CO2 (bicarbonate); low CO2 signals metabolic acidosis; high K? can be urgent.

  • BUN & CMP: overall renal/metabolic status, hydration context.

  • Mineral-Bone Markers: calciumphosphorusintact PTH25-OH vitamin D for CKD-MBD risk.

  • Anemia & Iron Studies: CBCferritiniron/TIBCtransferrin saturation.

  • Add-ons by scenario: urine culture (UTI), urine pH/calcium/uric acid or 24-hr stone profile (stones), ACR/PCR/24-hr protein (proteinuria), urine cytology (selected high-risk hematuria), autoimmune/viral serologies (etiology work-ups).

Quick Build Guide

Goal Start with Add if needed
Wellness baseline Creatinine/eGFR • Urine ACR • Urinalysis Electrolytes • CO2 • Calcium/Phosphorus
Diabetes or hypertension screen eGFR • ACR • Urinalysis Cystatin?C (borderline eGFR) • A1c • Lipid panel
UTI symptoms UA with microscopy Urine culture • hCG (when applicable) • Creatinine/CBC if febrile
Blood in urine (hematuria) UA with microscopy • Creatinine/eGFR ACR/PCR • Urine cytology (risk-based)
Protein in urine ACR or PCR • UA • eGFR 24-hr protein • Serum albumin • Lipids
Stone risk or history UA (pH, crystals) • eGFR Urine calcium/uric acid • 24-hr stone profile
AKI vs. CKD question Renal panel • UA Cystatin?C • Repeat eGFR/ACR over ≥3 months
CKD follow-up eGFR • ACR • Electrolytes • CO2 Calcium/Phosphorus • Intact PTH • 25-OH Vit D • CBC/Iron

How the Testing Process Works

  1. Choose your starting set: most people begin with eGFR (creatinine)urine ACR, and urinalysis.

  2. Provide samples: clean-catch urine and a standard blood draw; fasting is usually not required unless lipids/glucose are included.

  3. Confirm persistence: repeat abnormal eGFR/ACR over ≥3 months to distinguish temporary changes from CKD.

  4. Broaden as needed: add cystatin?C, electrolytes/CO2, mineral-bone and anemia labs, or targeted tests for UTIsstonesproteinuria, or hematuria.

  5. Review & plan: discuss results with your clinician; imaging or specialist referral may be recommended.

Interpreting Results (General Guidance)

  • eGFR: generally normal at ≥90<60 for ≥3 months supports CKD. Falling trends raise concern.

  • ACR: A1 (<30?mg/g) normal-mild; A2 (30–299) moderate; A3 (≥300) severe—higher categories increase risk at any eGFR.

  • Urinalysis: RBC casts/dysmorphic RBCs suggest glomerular disease; nitrite/leukocyte esterase support infection; crystals/pH inform stone risk.

  • Electrolytes/CO2: high K? and low CO2 can appear as CKD advances—require clinician review.

  • PTH/Calcium/Phosphorus: abnormalities point toward CKD-mineral and bone issues.

  • Anemia/iron: low hemoglobin with altered iron indices is common in CKD.
    Always interpret patterns over time with a qualified healthcare professional.

Choosing Panels vs. Individual Tests

  • Foundational kidney panel: eGFR (creatinine) • Urine ACR • Urinalysis

  • Refinement/confirmation: add cystatin?C when creatinine eGFR is borderline or muscle mass is atypical.

  • Complication checks: Electrolytes/CO2 • Calcium/Phosphorus • Intact PTH • 25-OH Vitamin D • CBC/Iron studies.

  • Scenario add-ons: Urine culture (UTI), stone profilePCR/24-hr proteinurine cytologyautoimmune/viral serologies when indicated.

FAQs

Do I need to fast for kidney tests?
No. Fast only if your order includes lipids or fasting glucose.

Why test ACR if my eGFR is normal?
ACR detects early kidney damage that can be present even when eGFR looks normal.

When should I add cystatin?C?
When eGFR is borderline or muscle mass is unusual; cystatin?C can confirm or refine kidney function estimates.

Can dehydration change my results?
Yes. Dehydration can raise creatinine and ACR. Rehydrate and repeat if advised.

What if I see blood or foam in my urine?
Both warrant urinalysis and ACR/PCR. Persistent findings need clinician follow-up.

How often should I screen with diabetes or high blood pressure?
Commonly once a year for eGFR, ACR, and urinalysis—more often if abnormal.

When should I see a nephrologist?
Consider referral for eGFR <30A3 albuminuriarapid decline, resistant hypertension, or unclear cause.

Related Categories & Key Tests

  • Upward: Kidney & Urinary Health Tests Hub

  • Sideways: Kidney Disease Tests • Kidney Health Tests • Renal Function Tests • Protein in Urine • Blood in Urine • Kidney Stone Risk • Urinary Tract Infection (UTI) Tests • Hypertension Tests • Diabetes Health

  • Key Tests (downward): Creatinine/eGFR • Cystatin?C (eGFRcys) • Urine ACR • Urinalysis with Microscopy • BUN • Electrolytes (Na/K/Cl) • Bicarbonate (CO2) • Calcium • Phosphorus • Intact PTH • 25-OH Vitamin D • CBC • Ferritin • Iron/TIBC • Transferrin Saturation • Urine Culture • Urine Calcium/Uric Acid • 24-Hour Stone Profile • Urine Cytology • ANA/C3/C4/ANCA/anti-GBM • Hepatitis B/C • SPEP/Free Light Chains

References

  • KDIGO — Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
  • National Kidney Foundation (KDOQI) — CKD detection, staging, and albuminuria testing.
  • American Diabetes Association — Standards of Care: CKD screening in diabetes.
  • American Heart Association — Hypertension and kidney disease risk statements.
  • American Urological Association — Microhematuria and stone disease evaluation (context).
  • ASN/ACP — Guidance on cystatin?C to confirm eGFR.
  • Clinical laboratory reviews on urinalysis, ACR/PCR, and electrolyte/acid–base assessment.

Available Tests & Panels

Your All Kidney Tests menu is pre-populated in the Ulta Lab Tests system. Start with eGFR (creatinine)urine ACR, and urinalysis. Use filters to add cystatin?Celectrolytes/CO2mineral-bone and anemia panels, or targeted testing for UTIsstonesproteinuria, and hematuria. Follow collection instructions and review results with your clinician to confirm findings, stage risk, and set a monitoring plan.

Compliance Disclaimer

Ulta Lab Tests provides direct access to lab testing for informational purposes. Results are not a substitute for professional medical advice, diagnosis, or treatment.

  • Page
  • 1
  • of
  • 6
  • Total Rows
  • 140
Name Matches

The Acetylcholine Receptor Binding Antibody Test detects antibodies targeting acetylcholine receptors, a hallmark of myasthenia gravis. This autoimmune disorder affects nerve-to-muscle communication, causing weakness and fatigue. The test helps confirm diagnosis, differentiate from other neuromuscular diseases, and guide treatment. Elevated antibody levels support early detection and ongoing management of myasthenia gravis.

Blood
Blood Draw

The Acetylcholine Receptor Blocking Antibody Test evaluates autoantibodies that block acetylcholine receptors, impairing nerve-to-muscle signaling. It is commonly ordered in the workup of suspected myasthenia gravis, where these antibodies contribute to muscle fatigue and weakness. This test, often performed with AChR binding and modulating antibody assays, provides valuable insight into autoimmune mechanisms affecting neuromuscular transmission.

Blood
Blood Draw

The Acetylcholine Receptor Modulating Antibody Test measures autoantibodies that cause loss or alteration of acetylcholine receptors on muscle cells, impairing nerve transmission. Elevated levels are commonly linked to myasthenia gravis, an autoimmune disorder causing muscle weakness. This test aids in identifying immune-mediated neuromuscular disease and helps evaluate disease severity.

Blood
Blood Draw

The Actin Smooth Muscle IgG Antibody Test detects autoantibodies against smooth muscle actin, often linked to autoimmune hepatitis and chronic liver disease. Elevated levels may indicate liver inflammation, cirrhosis, or other autoimmune conditions. Doctors use this blood test with liver panels and additional antibody tests to aid in diagnosis, monitor disease progression, and guide treatment decisions for patients with suspected autoimmune liver disorders.

Blood
Blood Draw
Also Known As: Actin IgG Antibody Test

The Albumin 24 Hour Urine Test evaluates the amount of albumin released in urine during a full day, serving as an indicator of kidney health. High albumin levels can signal early kidney damage from diabetes, hypertension, or chronic kidney disease. Collecting urine over 24 hours improves accuracy by reflecting daily fluctuations, offering important insight for detecting renal impairment, monitoring progression, and supporting long-term care.

Urine
Urine Collection
Also Known As: Urine Albumin Test, 24 Hour Microalbumin Test

The Albumin 24 Hour Urine with Creatinine Test measures albumin and creatinine excretion over 24 hours to evaluate kidney function. Elevated albumin (albuminuria) may signal early kidney disease, diabetes-related damage, or hypertension. By comparing albumin to creatinine, this test accounts for urine concentration and improves accuracy. Doctors use it to detect kidney injury, monitor chronic disease, and guide treatment or prevention strategies.

Urine
Urine Collection
Also Known As: Urine Albumin Test, 24 Hour Microalbumin Test

The Albumin Creatinine Ratio Timed Urine Test measures albumin and creatinine levels in a timed urine sample to evaluate kidney function. Elevated albumin excretion can indicate early kidney damage, diabetic nephropathy, or hypertension-related disease. By analyzing the albumin-to-creatinine ratio, this test provides insight into kidney filtration, urinary protein loss, and overall renal health monitoring.

Urine
Urine Collection
Also Known As: Urine Albumin Test, Timed Microalbumin Creatinine Ratio Test

The Albumin Random Urine Test measures the amount of albumin, a protein that can leak into urine when the kidneys are damaged. Elevated levels may indicate early kidney disease, often linked to diabetes, hypertension, or other chronic conditions. Doctors use this test to detect albuminuria, monitor kidney function, and guide treatment strategies. A random urine sample makes it a convenient tool for screening and long-term kidney health assessment.

Urine
Urine Collection
Also Known As: Urine Albumin Test, Random Microalbumin Test

The Albumin Random Urine Test with Creatinine measures albumin and creatinine levels in a urine sample to evaluate kidney health. Elevated albumin (microalbuminuria) may indicate early kidney disease, diabetes complications, or hypertension-related damage. Doctors use this test to detect kidney problems before symptoms appear, monitor chronic conditions, and guide treatment. It provides vital insight into renal function and long-term kidney disease management.

Urine
Urine Collection
Also Known As: Urine Albumin Test, Random Microalbumin Test, uACR Test

The Albumin Test measures albumin, the main protein made by the liver that maintains fluid balance and transports hormones, vitamins, and medications. Low albumin may indicate liver disease, kidney problems, malnutrition, or chronic inflammation, while high levels may reflect dehydration. Doctors order this test to evaluate swelling, fatigue, or abnormal labs. Results provide key insight into nutritional status, liver and kidney function, and overall metabolic health.

Blood
Blood Draw
Also Known As: ALB Test

The Albumin Timed Urine Test measures albumin levels excreted during a set time period to evaluate kidney function and detect early protein loss. Elevated results may indicate diabetic nephropathy, hypertension-related damage, or glomerular disease. This test supports monitoring of renal health, guiding detection of microalbuminuria and helping assess risks of chronic kidney disease or cardiovascular complications.

Urine
Urine Collection
Also Known As: Urine Albumin Test, Timed Microalbumin Test

The Alpha-2 Macroglobulin Test evaluates concentrations of A2M, a protein that binds and regulates proteases in the blood. Elevated levels may suggest nephrotic syndrome or liver fibrosis, while decreased values can occur in acute pancreatitis or severe liver disease. This test supports evaluation of immune activity, inflammatory processes, and systemic disorders affecting protein balance and organ health.

Blood
Blood Draw

The ANA IFA Panel Comprehensive screens for autoimmune disorders by detecting antinuclear antibodies and specific markers including dsDNA, Sm, Sm/RNP, Scl-70, and Sjögren’s SS-A/SS-B. Doctors order this panel for patients with joint pain, rash, fatigue, or suspected lupus, scleroderma, or Sjögren’s syndrome. Results provide critical insight into autoimmune activity, helping confirm diagnosis, monitor disease progression, and guide treatment decisions.

Also Known As: Comprehensive ANA Panel

The ANA Screen IFA with Reflex to Titer and Pattern Test detects antinuclear antibodies in blood to evaluate autoimmune activity. If positive, further testing identifies antibody concentration (titer) and fluorescence pattern, helping diagnose conditions like lupus, rheumatoid arthritis, or Sjögren’s syndrome. Doctors order this test to investigate symptoms such as joint pain, fatigue, rash, or swelling and to guide treatment for autoimmune and connective tissue disorders.

Also Known As: ANA Test, Antinuclear Antibody Screen Test

The Basic Metabolic Panel Plasma Test measures key blood chemistries including glucose, calcium, sodium, potassium, chloride, carbon dioxide, blood urea nitrogen, and creatinine. These markers provide insight into kidney function, electrolyte balance, and metabolic health. Clinicians often use the results to assess conditions such as dehydration, renal disease, or metabolic disorders and to monitor overall systemic health.

Blood
Blood Draw

The Basic Metabolic Panel (BMP) Test measures eight markers, including glucose, calcium, sodium, potassium, chloride, carbon dioxide, BUN, and creatinine, to evaluate kidney function, blood sugar, and electrolyte balance. Doctors use this panel to detect diabetes, dehydration, and kidney disease, or to monitor treatment. It is commonly ordered in routine exams, emergency care, or pre-surgical testing to assess overall metabolic and organ health.

Blood
Blood Draw
Also Known As: BMP Test, Chemistry Panel, Chemistry Screen, Chem 7, Chem 11, SMA 7, SMAC7, Basic Metabolic Test, Chem Test, Chem Panel Test 

The Beta-2-Microglobulin (B2M) Test measures levels of B2M, a protein found on most cell surfaces and released into the blood. Elevated levels may indicate multiple myeloma, lymphoma, chronic infections, or kidney disease. Doctors order this test to evaluate cancer stage, prognosis, or kidney function. Results provide essential insight into disease progression, immune activity, and treatment monitoring for blood cancers and renal disorders.

Blood
Blood Draw
Also Known As: B2M Test, β2-Microglobulin Test, Thymotaxin Test

Random
Phlebotomist

The BUN Creatinine Ratio Test compares blood urea nitrogen (BUN) to creatinine levels to assess kidney function and hydration status. A high ratio may indicate dehydration, gastrointestinal bleeding, or high protein intake, while a low ratio can suggest liver disease or malnutrition. Doctors order this test with kidney panels to evaluate fatigue, swelling, or abnormal lab results. Results help diagnose renal issues and guide treatment planning.

Blood
Blood Draw
Also Known As: Blood Urea Nitrogen to Creatinine Ratio

The Calcium 24 Hour Urine with Creatinine Test evaluates calcium excretion alongside creatinine to provide insight into kidney health, mineral balance, and bone metabolism. Elevated or low calcium may reflect kidney stones, parathyroid disease, osteoporosis, or metabolic disorders. This test supports monitoring of calcium regulation, renal function, and systemic conditions linked to skeletal health.

Urine
Urine Collection

The Carnitine Test measures carnitine levels in the blood to evaluate fatty acid metabolism and energy production. Abnormal results may indicate primary or secondary carnitine deficiency, often linked to metabolic disorders, malnutrition, or certain medications. Doctors use this test to investigate muscle weakness, hypoglycemia, or developmental delays and to monitor patients receiving treatment for metabolic or mitochondrial disease.

Blood
Blood Draw

The Catecholamines Fractionated Plasma Test measures plasma levels of dopamine, epinephrine, and norepinephrine, hormones that regulate stress response, blood pressure, and heart rate. Elevated levels may indicate pheochromocytoma, paraganglioma, or other adrenal and nervous system disorders. Doctors use this test to investigate symptoms like hypertension, headaches, sweating, or palpitations, and to monitor treatment of adrenal tumors.

Blood
Blood Draw

The CBC with H/H, RBC, Indices, WBC and Platelets Test evaluates overall blood health by measuring hemoglobin, hematocrit, red blood cell count, size and indices, white blood cell levels, and platelets. It helps detect anemia, infections, clotting disorders, and immune or bone marrow conditions. Frequently ordered in routine exams, this test supports diagnosis, monitoring of chronic disease, and assessment of general health.

Blood
Blood Draw
Also Known As: Complete Blood Count Test, Hemogram Test

The Ceruloplasmin Test measures levels of ceruloplasmin, a copper-carrying protein made in the liver, to evaluate copper metabolism and related disorders. Low levels may indicate Wilson’s disease, Menkes disease, or severe liver disease, while high levels may suggest inflammation or pregnancy. Doctors order this test for patients with liver problems, neurological symptoms, or abnormal copper levels. Results help diagnose metabolic disorders and guide treatment.

Blood
Blood Draw
Also Known As: Copper Oxide Test, Wilson’s Disease Test

Blood
Blood Draw

Improperly functioning kidneys can lead to what is known as kidney disease. Kidney Disease does not fall into one particular description. Instead, there are a variety of conditions that can cause kidney disease and even the loss of kidney function.

Various symptoms and signs of kidney disease depend on how the kidneys are affected. They fall into three main categories:

  • Pre-renal

Pre-renal describes decreased blood flow to the kidney. This reduced flow stops the kidneys from operating correctly. Over time, the reduced flow can damage the kidneys.

When blood flow to the kidneys decreases, it can happen quickly. Shock, severe dehydration, and sepsis are examples of conditions that can cause reduced blood flow. Heart failure and liver failure, for example, can also, over time, contribute to reduced blood flow.

  • Renal

Some conditions can affect the actual kidney. These conditions are called “renal.” When this happens, the kidney is damaged or impaired in function.

Examples of health conditions that contribute to a “renal” condition are:

  • Diabetes
  • Hypertension, otherwise known as high blood pressure
  • Autoimmune diseases such as Goodpasture syndrome, lupus or other abnormal immune responses
  • Infection such as an untreated urinary tract infection or UTI that has spread to the kidneys
  • Injury or trauma
  • Toxins such as ethylene glycol or heavy metals
  • Medications such as non-steroidal anti-inflammatory drugs or NSAIDs, analgesics or pain killers, and particular antibiotics
  • Certain contrast dyes that are used for imaging procedures
  • Damage to muscles otherwise known as rhabdomyolysis
  • Congenital renal disease (those that appear at birth) which includes kidneys that do not develop or form normally
  • Polycystic kidney disease which are disorders that are identified as multiple fluid-filled sacks or spaces within the kidneys

Post-renal

Post-renal kidney disease occurs when the drainage of the kidney is blocked. It can increase the pressure in the kidneys and prevent the organs from functioning. When there is an ongoing obstruction within the organs and, similar to decreased blood flow, the kidneys can be damaged. When there is obstruction of drainage from the kidneys, it can be due to health conditions such as:

  • Tumors
  • Kidney stones
  • An enlarged prostate, such as BPH (benign prostatic hyperplasia)

All functions of the kidney can be affected by some of these causes. Depending on the duration, they occur in one of three primary ways:

  • Acute Kidney Injury or AKI (an older name for AKI is acute renal failure or ARF) is defined as the rapid loss of kidney function. If suddenly, a person produces urine significantly less frequently and/or has a massive increase in the amount of waste products in the blood that are typically filtered out by the kidneys, the condition may be recognized.  AKI is often caused by trauma, medication that damages the kidneys, or illness. Many people who are hospitalized, such as those in intensive care and who are critically ill, commonly exhibit AKI. If AKI-related damage continues, it can become chronic kidney disease.
  • Chronic Kidney Disease, or CKD, occurs when a significant amount of kidney function is lost over time. The National Kidney Foundation reports that 30 million adults are suffering from CKD and that there are millions more that are at an increased risk. CKD is preventable. If it is found early, it can be treated to stop or delay the progression that leads to end-stage renal disease.
  • End-stage Renal Disease, or ESRD, is described as when kidney function is at a near or total loss. It is permanent. The only options to treat ESRD are dialysis or a kidney transplant.

Glomerular Damage

There are some contributors to kidney damage that initially affect only one part of the kidney, especially the glomerulus. The glomerulus filters blood to let water and small molecules move into the urine while retaining cells and large molecules, such as proteins. The appearance of glomerular damage manifests itself in three main ways:

  • Proteinuria is an increased amount of protein found in the urine. When there is mild damage, the glomeruli lose the ability to keep protein that can be detected in the urine. However, if the body can make up for the protein loss, there will be few to no symptoms.
  • Nephrotic syndrome is when the glomeruli are more severely damaged.  The type of damage can vary. Specifically, large amounts of protein (mainly albumin, a protein that helps to maintain the proper amount of water in the blood) get lost in one’s urine, making the body unable to compensate fully. People with nephrotic syndrome often have edema, which is an accumulation of fluid that causes swelling.
  • Glomerulonephritis, known as nephritic syndrome, may also indicate severe damage to the glomeruli.  The specific result is severe inflammation and damage to the functioning of the kidneys. This causes high blood pressure, accumulation of fluid, a decrease in urine production, and small amounts of protein and blood or red blood cells leaking into the urine.

Tumors of the Kidney

When there are tumors in the kidney, there is often no effect on the function of the organs. However, when they are detected, these tumors present as a mass in the kidney detectable through imaging and/or they can be felt by the patient, family, or medical practitioner. There may also be blood and protein in the urine.

Three significant tumors can appear in the kidney:

  • Renal cell carcinoma is cancer that can develop in adult kidneys.
  • Wilms tumor is a cancer that develops in the kidneys of children mostly those that are between the ages of 2 and 5.
  • Transitional cell carcinoma is cancer that often occurs in the bladder and can also develop in the lining of the ureters (which are the tubes that exist between the bladder and the kidney). In addition, sometimes it can appear in the kidney itself.

Risk Factors

  • Diabetes is when there is a continued high level of blood glucose as a result of uncontrolled diabetes that can gradually damage the nephrons located in the kidneys. Therefore, people with diabetes need to maintain good glucose control.
  • High Blood Pressure is known as hypertension and can damage the blood vessels inside the kidneys. Therefore, it’s essential to keep your blood pressure under control to help reduce the risk of kidney disease as well as other health problems.
  • Age: People over 60 are more likely to develop kidney disease. However, the condition can occur at any age.
  • Family History: If there is a history of kidney disease in the family, a person is at risk for developing it. For example, polycystic kidney disease or PKD is an inherited medical disorder.
  • Heart Disease: If you have been diagnosed with heart disease, you are at higher risk for developing kidney disease.
  • Certain Races: It is more common for Native Americans, African Americans, Hispanic Americans, Asians, and Pacific Islanders to get chronic kidney disease.

Signs and Symptoms

The condition of chronic kidney disease or CKD can creep up silently over the years. There may be no signs or symptoms, or the signs and symptoms can be so general that a person doesn’t know it’s related to kidney function. Regular health examinations with routine lab tests can help to detect the early warning signs of kidney disease.

Early warning signs of kidney disease include:

  • Blood in the urine (hematuria)
  • Protein in the urine (proteinuria)
  • Decreased estimated glomerular filtration rate, or eGFR
  • Elevated creatinine
  • Urea (blood urea nitrogen, or BUN)

Some other early warning signs:

  • Puffiness or swelling on the face, around the eyes, on the wrists, abdomen, thighs, ankles, etc.
  • Urine that is bloody, coffee-colored or foamy
  • Decreased quantity of urine that is out-of-the-ordinary
  • Issues with urinating, such as abnormal discharge, a burning feeling, or a change in the number of times you urinate, particularly at night
  • Flank or mid-back pain, pain below the ribs, close to where the kidneys are located
  • High blood pressure or hypertension

The worse the kidney disease gets, additional signs and symptoms may occur and are likely to occur in combination:

  • Itchy feeling
  • Tiredness
  • Loss of concentration
  • Loss of appetite
  • Nausea
  • Vomiting
  • Hands and feet numbness
  • Darkened skin
  • Muscle cramps
  • Gout

Acute Kidney Injury

Acute kidney injury, or AKI, is the sudden loss of kidney functioning. This is a condition that can be fatal and requires immediate treatment.

The symptoms include:

  • Reduced number of urinations
  • Fluid retention that causes swelling in the feet, ankles, and legs
  • Drowsiness
  • Fatigue
  • Shortness of breath
  • Nausea
  • Confusion
  • Seizures
  • Coma
  • Chest pain

Tests for Screening and Diagnosis

The National Kidney Disease Education Program (NKDEP) and The National Kidney Foundation (NKF) both recommend that if you are a person of high risk, you should be screened for kidney disease. The NKF recommends explicitly that if you have diabetes and are between the ages of 12 and 70, you should get tested at least once per year.

A child with type 1 diabetes should get a kidney disease screening within five years of the diagnosis. A child with type 2 diabetes should get a kidney disease screening as soon as the diagnosis. After the initial screening, such children should be screened for kidney disease once per year.

Currently, no consensus exists on screening people who have no risk symptoms or factors.  However, both the NKF and the NKDEP recommend two tests, in addition to testing for blood pressure, to screen for kidney disease:

1. Urine Protein

Urine albumin as well as albumin/creatinine ratio (ACR): These tests will look for tiny amounts of albumin in the urine. According to the American Diabetes Association, ACR is the recommended test for screening for albumin in the urine, also known as microalbuminuria.

Urinalysis: This routine test can find protein, red blood cells, and white blood cells in the urine. These are not typically found in the urine and, therefore, can indicate if there may be kidney disease.

Urine total protein and urine protein to creatinine ratio (UP/CR): This test detects not only albumin but also any other proteins that may be in the urine.

2. Estimated glomerular filtration rate (eGFR) is a calculation that is based on a blood creatinine or cystatin C test. Also, other variables, such as sex, age, race (for example, if you are African-American or non-African-American) are taken into consideration depending on the equation used.  The eGFR rate means the amount of blood filtered by the glomeruli per minute. When kidney function declines, the filtration rate also drops.

General Tests for Kidney Function and Disease:https://www.ultalabtests.com/test/comprehensive-metabolic-panel-cmp

A renal panel is a group of tests that can be used to evaluate how the kidneys are functioning. They can also screen for, monitor, or diagnose kidney disease. The test panels vary by laboratory, but generally include:

  • Electrolytes, specifically potassium, sodium, chloride, and carbon dioxide (CO2)
  • Urea (urea nitrogen or blood urea nitrogen, BUN)

There may be calculated values that include eGFR, urea (BUN) to creatinine ratio, and anion gap.

Each of the tests above can be ordered individually.

Further Tests:

  • Creatinine clearance: The patient produces a 24-hour collection. A blood sample is tested as well. Both of these tests will measure creatinine levels. If the level of creatinine clearance is decreased, it may signal a decrease in kidney function.
  • Parathyroid hormone (PTH) controls calcium levels in the blood. PTH levels are often increased in the presence of kidney disease.
  • Hemoglobin, which is part of a complete blood count or CBC, may be performed to detect anemia. Kidneys typically create the erythropoietin hormone that controls red blood cell production. It can be negatively affected by kidney damage. A medical laboratory can also measure erythropoietin directly, but it is not a routine test.
  • Beta 2 microglobulin (B2M) tests may be ordered, along with other kidney function tests, to evaluate kidney damage and disease, as well as to distinguish between disorders affecting the renal tubules and the glomeruli.
  • Uric acid, which is eliminated from the body by the kidneys, is often elevated when there is chronic kidney disease.
  • Vitamin D is necessary for managing calcium and phosphate metabolism. It also plays a part in cell kidney, immune system, and cardiac functions.

After considering a person’s physical condition, medical history, and routine lab test results, additional tests may be ordered, such as:

  • A blood culture may be used to identify sepsis, which can cause kidney damage.
  • Hepatitis B and C tests detect a hepatitis viral infection that is associated with some kinds of kidney disease.

Kidney stone risk panel assesses the risks of developing a kidney stone. It is also used to suggest and monitor treatment and prevention.

Kidney stone analysis reveals the composition of a kidney stone that has passed or that is removed from the urinary tract. The test may also be done to determine how the kidney stone was formed, how other stones can be treated, and how to prevent another occurrence.

  • Myoglobin is another test that may be ordered for patients who have had severe damage to their skeletal muscles (rhabdomyolysis).  When there is rhabdomyolysis, both urine and blood levels of myoglobin can quickly rise.

Structural problems or blockage can occur in the kidneys and, if suspected, a medical professional is likely to order an image. The techniques used for imaging include ultrasound, CT scan (or computed tomography), intravenous pyelogram (or IVP), and isotope scan.

Kidney Biopsy

If there is structural damage to the kidney suspected, a kidney biopsy can help establish the nature and extent of the damage. A medical professional analyzes a small piece of kidney tissue that is obtained with the use of a biopsy needle and diagnostic imaging equipment. This can be useful when disease of the glomeruli or tubules is suspected.

Tests for Biomarkers of Acute Kidney Injury

There are a few biomarkers that are becoming popular as early indicators of acute kidney injury (or AKI). Traditional tests, such as serum creatinine, a kidney function test, may not detect AKI as early as some other tests highlighted below. Early detection of AKI is critical. This is because injury to the kidneys can occur rapidly over hours to days. These AKI biomarkers are still under study but may become more widely available in the future.

AKI is a severe condition that creates millions of dollars in cost to the American healthcare system every year. However, AKI biomarkers do not directly help in the treatment of AKI as there are no particular FDA-approved therapies that are currently available. When a diagnosis of AKI is produced, imaging scans of the kidneys are frequently performed to rule out the possibility of an obstruction in the urinary tract. Supportive treatment, such as an introduction of IV fluids or a transfusion of blood components. If a person is in shock, drugs to improve blood pressure and heart function may be provided. Dialysis may be dictated if a person does not spontaneously recover from AKI.

Examples of New AKI Tests that Look Promising

Urinary insulin-like growth factor-binding protein 7 (IGFBP7), as well as urinary tissue inhibitor of metalloproteinases-2 (TIMP-2), are two markers that have been combined into a point-of-care test, and it is the first test that has been approved by the U.S. Food and Drug Administration to determine what the risk is for a critically ill patient to develop AKI within 12 hours.

Neutrophil gelatinase-associated lipocalin (NGAL) is a protein found in many tissues in the body, including kidney cells.  The level of NGAL rises rapidly when there is AKI (within 2 to 4 hours), making it a good indicator.  Other factors are also under study.  These include biomarkers like metalloproteinase 2 (a tissue inhibitor known as TIMP-2). They also include liver-type fatty-acid-binding protein (or L-FABP). Two other biomarkers under study include interleukin 18 (or IL-18) as well as kidney injury molecule 1 (or KIM-1).